Class Action Defense

Representative experience
- Defense of Merck & Co. in three class actions concerning the pain relief drug Vioxx.
- Defense of GlaxoSmithKline in class action litigation concerning the drug Avandia (indicated for diabetes type 2).
- Defense of Eli Lilly & Co. in a class action litigation concerning the drug Zyprexa (indicated for schizophrenia and bipolar disorder).
- Defense of Solbar Hatzor. in an NIS 112 million class action claim.
- Defense of a large Israeli investment bank in a class action claim in the amount of NIS 60 million.
- Defense of an accounting firm in an NIS 25 million class action for professional negligence.
- Defense of a publicly traded company in a NIS 170 million class action alleging misrepresentation to investors.
- Defense of a publicly traded company in a multi-million dollar class action alleging a violation of mandatory tender offer rules.
- Defense of the Tel Aviv and Eilat municipalities in class actions alleging illegal collection of water and sewage fees.
- Defense of the Israeli Yellow Pages in a class action claim regarding its business practices.

Practice area's Partners:
Leshem, Israel (Reli)
Weisman, Nadav
Rosovsky, Eyal
Antonelli, Yael
Arbel, Neta
Avrahami, Hagit
Bar, Royi
Bar-Shalom, Liran
Ben Artzi Halpern, Merav
Birger, Issar
Bursztyn, Ali
Dalach, Roy
Dolev, Amir
Ettinger, Yossi
Fremder, Adi
Frishtik, Gidi
Gellert, Alon
Gilad, Rotem
Goldstein, David
Kedem, Dror
Koppel-Aviv, Adi
Landa, Rami
Laron, Edan
Levi, Doron
Lipsky-Taichman, Bat-hen
Magen, Alon
Niemoj, Asaf
Oestreicher, Yoav
Paz, Daniel
Peleg, Ron
Rakover, Ariel
Ramot, Sivan
Reichart, Lior
Roginkin, Boris
Sasson, Yuval Z.
Schiff, Gilad
,
Shapira, Adam
Tesler, Michael
Yoeli, Alon
Ziv, Ronen